SCHEMBL8690349

SCHEMBL8690349

C1=C2NNCCC2CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9416877 0.91
SCHEMBL3699545 0.80
SCHEMBL37603 0.80
SCHEMBL11593833 0.78
SCHEMBL419917 0.76 CCR2 (0.31)
SCHEMBL16246596 0.74 CCR2 (0.36)
SCHEMBL27467506 0.68 NISCH (0.34)
SCHEMBL22510032 0.68 CCR2 (0.39)
SCHEMBL56810 0.67
SCHEMBL11738873 0.67 MAPT (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110291090-A Bentyl as novel jak kinase inhibitor 利奥制药有限公司 2019-09-27 CN claimed
CN-107074804-A Carbazole derivates 百时美施贵宝公司 2017-08-18 CN claimed
CN-110291090-A Bentyl as novel jak kinase inhibitor 利奥制药有限公司 2019-09-27 CN disclosed
CN-105085525-B Isoquinolin sulfonyl derivative as RHO kinase inhibitor 南京明德新药研发股份有限公司 2019-01-04 CN disclosed
CN-107074804-A Carbazole derivates 百时美施贵宝公司 2017-08-18 CN disclosed
US-5834499-A TREATING GASTROINTESTINAL DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-10 US disclosed
EP-0749966-A1 5-HT 3 RECEPTOR AGONIST, NOVEL THIAZOLE DERIVATIVE, AND INTERMEDIATE THEREFOR YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-12-27 EP disclosed